Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.
Nonperfusion area detected by swept-source optical coherence tomography angiography (OCTA) may predict diabetic nephropathy ...
Background: Diabetic Nephropathy (DN) is the leading cause of End-Stage Renal Disease (ESRD) globally. This study aimed to ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association ...
Whether estimating the probability that a disease is present or forecasting risk of deterioration,1 readmission,2 or death,3 most contemporary clinical artificial intelligence (AI) systems are ...
In this latest episode of the NeuroOp Guru in collaboration with Ophthalmology Times, host Andrew G. Lee, MD, is joined by ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
UAB researchers have launched DiaClue, a free web-based tool that helps clinicians classify diabetes into five subtypes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results